Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer (mCRC). A Multicenter, Single Arm Phase I/II Academic Trial

NCT00444041 is registered in ClinicalTrials.gov with Austrian Society Of Surgical Oncology as lead sponsor.

NCT NCT00444041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00444041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer (mCRC). A Multicenter, Single Arm Phase I/II Academic Trial
Lead sponsor
Austrian Society Of Surgical Oncology
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2007
Completion date
December 31, 2009
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer